Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator
Author(s) -
Robert J. Russo,
H. S. Costa,
Patricia D. Silva,
Jeffrey L. Anderson,
Aysha Arshad,
Robert W Biederman,
Noel G. Boyle,
Jennifer V. Frabizzio,
Ulrika BirgersdotterGreen,
Steven L. Higgins,
Rachel Lampert,
Christian Machado,
Edward T. Martin,
Andrew L. Rivard,
Jason Rubenstein,
Raymond Schaerf,
Jennifer Schwartz,
Dipan J. Shah,
Gery Tomassoni,
Gail T. Tominaga,
Allison Tonkin,
Seth Uretsky,
Steven Wolff
Publication year - 2017
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1603265
Subject(s) - medicine , magnetic resonance imaging , contraindication , cardiology , lead (geology) , implantable cardioverter defibrillator , ventricular tachycardia , atrial flutter , ventricular fibrillation , radiology , atrial fibrillation , pathology , alternative medicine , geomorphology , geology
The presence of a cardiovascular implantable electronic device has long been a contraindication for the performance of magnetic resonance imaging (MRI). We established a prospective registry to determine the risks associated with MRI at a magnetic field strength of 1.5 tesla for patients who had a pacemaker or implantable cardioverter-defibrillator (ICD) that was "non-MRI-conditional" (i.e., not approved by the Food and Drug Administration for MRI scanning).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom